Eculizumab dosing in infants

Eculizumab dosing in infants

Eculizumab is the therapy of choice for patients with atypical hemolytic uremic syndrome (aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children and 5 infants) and one prospective trial (22 patients and 5 infants). This case report highlights the need for more preci...

Full description

Bibliographic Details
Main Authors: M Kobrzynski, B Wile, S S Huang, G Filler
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Indian Journal of Nephrology
Subjects:
Atypical hemolytic uremic syndrome
biologic
eculizumab
dosing
pediatrics
Online Access:http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2018;volume=28;issue=1;spage=73;epage=75;aulast=Kobrzynski

Internet

http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2018;volume=28;issue=1;spage=73;epage=75;aulast=Kobrzynski

Similar Items